Oral bioavailability and pharmacokinetic characteristics of ketoprofen enantiomers after oral and intravenous administration in Asian elephants (Elephas maximus)

American Journal of Veterinary Research

Volumn 64, Issue 1, 2003, Pages 109-114

  Hunter, Robert P ^a   Isaza, Ramiro ^b   Koch, David E ^a  

^a Analytical and Toxicological Services   (United States)

^b KANSAS STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG METABOLITE; KETOPROFEN;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; ASIAN; BLOOD SAMPLING; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOSE RESPONSE; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DETERMINATION; DRUG DISTRIBUTION; DRUG EFFICACY; DRUG HALF LIFE; DRUG SAFETY; DRUG STRUCTURE; ELEPHANT; ENANTIOMER; FEMALE; LIQUID CHROMATOGRAPHY; MALE; MASS SPECTROMETRY; MEAN RESIDENCE TIME; NONHUMAN; RACEMIC MIXTURE; STATISTICAL ANALYSIS; VALIDATION PROCESS;

ADMINISTRATION, ORAL; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; AREA UNDER CURVE; BIOLOGICAL AVAILABILITY; CROSS-OVER STUDIES; ELEPHANTS; HALF-LIFE; INJECTIONS, INTRAVENOUS; KETOPROFEN; MALE; RANDOM ALLOCATION; STEREOISOMERISM;

ANIMALIA; ELEPHANT; ELEPHANTIDAE; ELEPHAS; ELEPHAS MAXIMUS;

EID: 0037250882     PISSN: 00029645     EISSN: None     Source Type: Journal    
DOI: 10.2460/ajvr.2003.64.109     Document Type: Article

References (41)

1. Bush M, Raath JP, de Vos V, et al. Serum oxytetracycline levels in free-ranging male African elephants (Loxodonta africana) injected with a long-acting formulation. J Zoo Wildl Med 1996;27:382-385.
2. Bush M, Stoskopf MK, Raath JP, et al. Serum oxytetracycline concentrations in African elephant (Loxodonta africana) calves after long-acting formulation injection. J Zoo Wildl Med 2000;31:41-46.
3. Gulland FMD, Carwardine PC. Plasma metronidazole levels in an Indian elephant (Elephas maximus) after rectal administration. Vet Rec 1987;120:440.
4. Lodwick LJ, Dubach JM, Phillips LG, et al. Pharmacokinetics of amikacin in African elephants (Loxodonta africana). J Zoo Wildl Med 1994;25:367-375.
5. Page CD, Mautino M, Derendorf HD, et al. Comparative pharmacokinetics of trimethoprim-sulfamethoxazole administered intravenously and orally to captive elephants. J Zoo Wildl Med 1991; 22:409-416.
6. Rosin E, Schultz-Darken N, Perry B, et al. Pharmacokinetics of ampicillin administered orally in Asian elephants (Elaphus maximus). J Zoo Wildl Med 1993;24:515-518.
7. Schmidt MJ. Penicillin G and amoxicillin in elephants: a study comparing dose regimens administered with serum levels achieved in healthy elephants. J Zoo Anim Med 1978;9:127-136.
8. Mortenson J. Determining dosages for antibiotic and anti-inflammatory agents. In: Csuti B, Sargent EL, Bechert US, eds. The elephant's foot: prevention and care of foot conditions in captive Asian and African elephants. Ames, Iowa: Iowa State University Press, 2001;141-144.
9. Olsen JH. Antibiotic therapy in elephants. In: Murray ME, Miller RE, eds. Zoo & wildlife medicine: current therapy 4. Philadelphia: WB Saunders Co, 1999;533-541.
10. Landoni MF, Lees P. Pharmacokinetics and pharmacodynamics of ketoprofen enantiomers in the horse. J Vet Pharmacol Ther 1996;19:466-474.
11. Owens JG, Kamerling SG, Barker SA. Pharmacokinetics of ketoprofen in healthy horses and horses with acute synovitis. J Vet Pharmacol Ther 1995;18:187-195.
12. Sams R, Gerken DF, Ashcraft SM. Pharmacokinetics of ketoprofen after multiple intravenous doses to mares. J Vet Pharmacol Ther 1995;18:108-116.
13. Caldwell J. The importance of stereochemistry in drug action and disposition. J Clin Pharmacol 1992;32:925-929.
14. Landoni MF, Soraci AL, Delatour P, et al. Enantioselective behaviour of drugs used in domestic animals: a review. J Vet Pharmacol Ther 1997;20:1-16.
15. Lee EJD, Williams KM. Chirality-clinical pharmacokinetic and pharmacodynamic considerations. Clin Pharmacokinet 1990;18:339-345.
16. Testa B. Chiral aspects of drug metabolism. Trends Pharmacol Sci 1986;7:60-64.
17. Landoni MF, Lees P. Chirality: a major issue in veterinary pharmacology. J Vet Pharmacol Ther 1996;19:82-84.
18. Brune K, Geisslinger G, Menzel-Soglowek S. Pure enantiomers of 2-arylpropionic acids: tools in pain research and improved drugs in rheumatology. J Clin Pharmacol 1992;32:944-952.
19. Aberg G, Ciofalo VB, Pendleton RG, et al. Inversion of (R)-to (S)-ketoprofen in eight animal species. Chirality 1995;7:383-387.
20. Alarcon de la Lastra C, Nieto A, Martin MJ, et al. Gastric toxicity of racemic ketoprofen and its enantiomers in rat: oxygen radical generation and COX-expression. Inflamm Res 2002;51:51-57.
21. Ariëns EJ. Nonchiral, homochiral and composite chiral drugs. Trends Pharmacol Sci 1993;14:68-75.
22. Owens JG, Kamerling SG, Stanton SR, et al. Effects of ketoprofen and phenylbutazone on chronic hoof pain and lameness in the horse. Equine Vet J 1995;27:296-300.
23. Eichhold TH, Bailey RE, Tanguay SL, et al. Determination of (R)- and (S)-ketoprofen in human plasma by liquid chromatography/tandem mass spectrometry following automated solid-phase extraction in the 96-well format. J Mass Spectrom 2000;35:504-511.
24. Gibaldi M, Perrier D. Pharmacokinetics. 2nd ed. Marcel Dekker Inc, New York, 1982;409-417.
25. Riviere JE. Comparative pharmacokinetics: principles, techniques, and applications. Ames, Iowa: Iowa State University Press, 1999;148-167.
26. Daniel WW. Applied nonparametric statistics. Boston: PWS-Kent Publishing Co, 1990;150-155.
27. Castro E, Soraci A, Fogel F, et al. Chiral inversion of R(-) fenoprofen and ketoprofen enantiomers in cats. J Vet Pharmacol Ther 2000;23:265-271.
28. Landoni MF, Cunningham FM, Lees P. Pharmacokinetics and pharmacodynamics of ketoprofen in calves applying PK/PD modeling. J Vet Pharmacol Ther 1995;18:315-324.
29. Navarre CB, Ravis WR, Campbell J, et al. Stereoselective pharmacokinetics of ketoprofen in llamas following intravenous administration. J Vet Pharmacol Ther 2001;24:223-226.
30. Arifah AK, Landoni MF, Frean SP, et al. Pharmacodynamics and pharmacokinetics of ketoprofen enantiomers in sheep. Am J Vet Res 2001;62:77-86.
31. Landoni MF, Lees P. Influence of formulation on the pharmacokinetics and bioavailability of racemic ketoprofen in horses. J Vet Pharmacol Ther 1995;18:446-450.
32. Al Katheeri NA, Wasfi IA, Lambert M, et al. Pharmacokinetics of ketoprofen enantiomers; after intravenous administration of racemate in camels: effect of gender. J Vet Pharmacol Ther 2000;23:137-143.
33. Foster RT, Jamali F. Stereoselective pharmacokinetics of ketoprofen in the rat. Influence of route of administration. Drug Metab Dispos 1988;16:623-626.
34. Abas A, Meffin PJ. Enantioselective disposition of 2-arylpropionic acid nonsteroidal anti-inflammatory drugs. IV. Ketoprofen disposition. J Pharmacol Exp Ther 1987;240:637-641.
35. Jamali F, Russell AS, Foster RT, et al. Ketoprofen pharmacokinetics in humans: evidence of enantiomeric inversion and lack of interaction. J Pharm Sci 1990;79:460-461.
36. Al Katheeri NA, Wasfi IA, Lambert M. Pharmacokinetics and metabolism of ketoprofen after intravenous and intramuscular administration in camels. J Vet Pharmacol Ther 1999;22:127-135.
37. Tanaka Y, Shimomura Y, Hirota T, et al. Formation of glycine conjugate and (-)-(R)-enantiomer from (+)-(S)-2-phenylproprionic acid suggesting the formation of the CoA thioester intermediate of (+)-(S)-enantiomer. Chirality 1992;4:342-348.
38. Verde CR, Simpson MI, Frigoli A, et al. Enantiospecific pharmacokinetics of ketoprofen in plasma and synovial fluid of horses with acute synovitis. J Vet Pharmacol Ther 2001;24:179-185.
39. Mikota SK, Sargent E, Georgeian L. Medical management of the elephant. West Bloomfield, Mich: Indira Publishing House, 1994.
40. Folwer ME. An overview of foot conditions in Asian and African elephants. In: Csuti B, Sargent EL, Bechert US, eds. The elephant's foot: prevention and care of foot conditions in captive Asian and African elephants. Ames, Iowa: Iowa State University Press, 2001;3-7.
41. Nolan AM. Pharmacology of analgesic drugs. In: Flecknell P, Waterman-Pearson A, eds. Pain management in animals. London: WB Saunders Co, 2000;21-52.